Skip to main content
. 2022 Aug 1;74:56. doi: 10.1186/s43044-022-00297-3

Table 3.

Drug use characteristics of the cases

Permanent PM implantation in the follow-up
(−)
n = 128
Permanent PM implantation in the follow-up
(+)
n = 49
p value
1 drug risk factor 94 (73.4%) 44 (89.8%) 0.013
> 1 drug risk factor 34 (26.6%) 5 (10.2%) 0.013
Calcium channel blocker 32 (25.0%) 5 (10.2%) 0.022
Digoxin 8 (6.3%) 1 (2%) 0.448
Beta blocker 103 (80.5%) 45 (91.8%) 0.053
Amiodarone 10 (7.8%) 0 (0.0%) 0.064